A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: Implication for the intense tumor infiltration by T lymphocytes and macrophages

Human Pathology

Volumn 32, Issue 1, 2001, Pages 42-49

  Tang, Kin Fai ^a   Tan, Sioh Yang ^a   Chan, Soh Ha ^a   Chong, Siew Meng ^a   Loh, Kwok Seng ^a   Tan, Luke Kim Siang ^a   Hu, Huaizhong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CC chemokines; Infiltrating T lymphocyte; Macrophage; Nasopharyngeal carcinoma

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0035125764     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.20886     Document Type: Article

References (30)

1. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization - A correlation with WHO histologic subtypes
2. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas
3. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
4. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells
5. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP 1, and LMP2 transcripts
6. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: Potential use in diagnosis
7. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma: Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells
8. Lymphocyte subsets in tumor of patients with undifferentiated nasopharyngeal carcinoma: Presence of lymphocytes with the phenotype of activated T cells
9. Cytotoxic potential despite impaired activation pathways: T lymphocytes infiltrating nasopharyngeal carcinoma
10. Increased production of interferon-γ in nasopharyngeal carcinoma: Indicative of an activated status
11. Control of apoptosis in Epstein-Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation
12. Chemokines-chemotactic cytokines that mediate inflammation
13. Chemokines and leukocyte traffic
14. Chemokines: Signal lamps for trafficking of T and B cells for development and effector function
15. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokines
16. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer
17. Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung
18. Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha
19. Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr virus-associated nasopharyngeal carcinoma
20. + T cells
21. Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: Correlation with humoral immune response to lytic replication of Epstein-Barr virus
22. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
23. Undifferentiated, nonkeratinizing, and squamous-cell carcinoma of the nasopharynx-variants of Epstein-Barr virus-infected neoplasia
24. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma
25. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with antilatent membrane-protein antibody
26. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
27. Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy
28. CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells
29. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells
30. T-cell-mediated activation of macrophages